tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Collegium Pharmaceutical price target raised to $37 from $36 at Piper Sandler
PremiumThe FlyCollegium Pharmaceutical price target raised to $37 from $36 at Piper Sandler
3M ago
Strong Buy Rating for Collegium Pharmaceutical Driven by Robust 2025 Performance and Growth Potential
Premium
Ratings
Strong Buy Rating for Collegium Pharmaceutical Driven by Robust 2025 Performance and Growth Potential
3M ago
Collegium Pharmaceutical Reports Strong Q1 2025 Growth
Premium
Company Announcements
Collegium Pharmaceutical Reports Strong Q1 2025 Growth
3M ago
Buy Recommendation for Collegium Pharmaceutical Driven by Stability and Growth Potential
PremiumRatingsBuy Recommendation for Collegium Pharmaceutical Driven by Stability and Growth Potential
4M ago
Collegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk
Premium
Ratings
Collegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk
4M ago
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning
Premium
Ratings
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning
4M ago
Collegium Pharmaceutical Reports Record 2024 Financial Results
PremiumCompany AnnouncementsCollegium Pharmaceutical Reports Record 2024 Financial Results
5M ago
Collegium Pharmaceutical Reports Record 2024 Financial Results
Premium
Company Announcements
Collegium Pharmaceutical Reports Record 2024 Financial Results
5M ago
Collegium Pharmaceutical backs FY25 revenue view $735M-$750M, consensus $740.44M
Premium
The Fly
Collegium Pharmaceutical backs FY25 revenue view $735M-$750M, consensus $740.44M
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100